Enzolytics Inc.
ENZC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | – | 58.2% | – | 91.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -4,019.3% | – | -306% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -4,123.1% | – | -334.5% |
| EPS Diluted | -0 | -0.001 | -0.001 | -0 |
| % Growth | 57.1% | 30% | -400% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |